1. Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B 
Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han, Sang Hoon Ahn 
Clinical Gastroenterology and Hepatology 
Volume 14, Issue 11, Pages e6 (November 2016)
DOI: /j.cgh
Copyright © 2016 AGA Institute Terms and Conditions

2. Figure 1
Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between those with LS value ≤13 kPa and with LS value >13 kPa (both P < .001).
Clinical Gastroenterology and Hepatology  , e6DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

3. Figure 2
Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between 2 groups in the entire population (both P > .05).
Clinical Gastroenterology and Hepatology  , e6DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

4. Figure 3
Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between 2 groups using PSM-1 and risks of HCC (C) and LRE (D) between 2 groups using PSM-2 (all P > .05).
Clinical Gastroenterology and Hepatology  , e6DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

5. Supplementary Figure 1
Kaplan-Meier curves comparing risk of HCC (A) and LRE (B) among LAM group without genotypic resistance, LAM group with rescue therapy, and ETV group (all P > .05).
Clinical Gastroenterology and Hepatology  , e6DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

6. Supplementary Figure 2
Analysis in patients with LS value ≤13 kPa; Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between two groups, risks of HCC (C) and LRE (D) between two groups using PSM-1, and risks of HCC (E) and LRE (F) between two groups using PSM-2 (all P > .05).
Clinical Gastroenterology and Hepatology  , e6DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

7. Supplementary Figure 3
Analysis in patients with LS value >13 kPa; Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between two groups, risks of HCC (C) and LRE (D) between two groups using PSM-1, and risks of HCC (E) and LRE (F) between two groups using PSM-2 (all P > .05).
Clinical Gastroenterology and Hepatology  , e6DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

8. Supplementary Figure 4
Analysis in patients with LS value ≤8 kPa; Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between two groups, risks of HCC (C) and LRE (D) between two groups using PSM-1, and risks of HCC (E) and LRE (F) between two groups using PSM-2 (all P > .05).
Clinical Gastroenterology and Hepatology  , e6DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

9. Supplementary Figure 5
Analysis in patients with 8 kPa <LS value ≤13 kPa; Kaplan-Meier curves comparing risks of HCC (A) and LRE (B) between two groups, risks of HCC (C) and LRE (D) between two groups using PSM-1, and risks of HCC (E) and LRE (F) between two groups using PSM-2 (all P > .05).
Clinical Gastroenterology and Hepatology  , e6DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions